Search

Ravi Kumar Erukulla

from Dayton, NJ
Age ~62
Get Report
Also known as:
Ravi K Erukulla, Ravz Kumar Erukulla, Ravi K Brukulla, Revi K Erukulla, Ravi K Erukula, Ravi A, Kumar Erukulla
Phone and address:
1209 Blossom Cir, South Brunswick, NJ 08810
(732) 230-3263
Related to:
Reshma Erukulla, 34Madhavi L Erukulla, 56Manjit M Kumar, 48Rashpal P Kumar, 70Jagjit Kumar, 41Varinder Kumar, 46Santosh Kumar, 35
Connected to:
Imelda F Erum, 49Darren E Erutti, 55Darlene M Ervanowitz, 66Larry D Ervans, 81Donna L Ervast, 59Mikael Ervasti, 27Andrew S Ervay, 54Christine F Ervelli, 72Larry E Erven, 80Marisa Erven, 42

Ravi Erukulla Phones & Addresses

  • 1209 Blossom Cir, Dayton, NJ 08810 (732) 230-3263 (732) 355-1930
  • 1309 Blossom Cir, Dayton, NJ 08810 (732) 355-1930
  • Princeton, NJ
  • Flushing, NY
  • Plainsboro, NJ

Resumes

Resumes

Ravi Erukulla Photo 1

Ravi Erukulla

View page
Location:
1209 Blossom Cir, Dayton, NJ 08810
Industry:
Biotechnology
Work:
Apex Pharmaceuticals, Inc.
Director of Quality Control
Medical Diagnostic Laboratories, L.l.c. (Mdl)
Director of R and D
Purdue Pharma L.p.
Project Manager
Vyteris
Senior Scientist
Elan
Scientist
Education:
Queens College
Indian Institute of Technology Iit
Doctorates, Doctor of Philosophy P.g. College of Law, Basheerbagh
Master of Science, Masters P.g. College of Law, Basheerbagh
Bachelors, Bachelor of Science
Skills:
Biotechnology
Pharmaceutical Industry
Drug Discovery
Analytical Chemistry
Validation
Life Sciences
Fda
Clinical Trials
Medical Devices
Lifesciences
Gmp
Clinical Development
Technology Transfer
Analytical Skills
Chemistry
Project Management
Interests:
Social Services
Ravi Erukulla Photo 2

Ravi Erukulla

View page

Publications

Us Patents

Peptide-Lipid Conjugates, Liposomes And Lipsomal Drug Delivery

View page
US Patent:
6339069, Jan 15, 2002
Filed:
Jun 29, 1999
Appl. No.:
09/343650
Inventors:
Paul R. Meers - Princeton NJ
Charles Pak - Princeton NJ
Shaukat Ali - Monmouth Junction NJ
Andrew Janoff - Yardley PA
J. Craig Franklin - Skillman NJ
Ravi K. Erukulla - Plainsboro NJ
Donna Cabral-Lilly - Princeton NJ
Patrick L. Ahl - Princeton NJ
Assignee:
Elan PharmaceuticalsTechnologies, Inc. - King of Prussia PA
International Classification:
A61K 4800
US Classification:
514 44, 424450, 4353201, 435455, 435458
Abstract:
Peptide-lipid conjugates are incorporated into liposomes so as to selectively destabilize the liposomes in the vicinity of target peptidase-secreting cells, and hence, to deliver the liposomes to the vicinity of the target cells, or directly into the cells. The liposomes can thus be used to treat mammals for diseases, disorders or conditions, e. g. , tumors, microbial infection and inflammations, characterized by the occurrence of peptidase-secreting cells.

Modular Targeted Liposomal Delivery System

View page
US Patent:
7060291, Jun 13, 2006
Filed:
Nov 17, 2000
Appl. No.:
10/130951
Inventors:
Paul R. Meers - Princeton Junction NJ, US
Tong Shangguan - Princeton NJ, US
Donna Cabral-Lilly - Princeton NJ, US
Patrick Ahl - Princeton NJ, US
Ravi Erukulla - Plainsboro NJ, US
Andrew Janoff - Princeton Junction NJ, US
Assignee:
Transave, Inc. - Monmouth Junction NJ
International Classification:
A61K 9/127
US Classification:
424450, 424 121, 424 9321, 424 951, 424417
Abstract:
A liposome including a fusogenic liposome, a linking moiety and a targeting moiety. The fusogenic liposome is a lipid bilayer encapsulating contents. The linking moiety is electrostatically bound to the lipid bilayer, and the targeting moiety is covalently bound to the linking moiety. The liposome may also include a stabilizing moiety interposed between the linking and targeting moieties, and covalently bound to both. Alternatively, the stabilizing and targeting moieties may be covalently bound to separate linking moieties, the linking moieties being electrostatically bound to the lipid bilayer.

Modular Targeted Liposomal Delivery System

View page
US Patent:
20060172003, Aug 3, 2006
Filed:
Feb 22, 2006
Appl. No.:
11/359964
Inventors:
Paul Meers - Princeton Junction NJ, US
Tong Shangguan - Princeton NJ, US
Donna Cabral-Lilly - Princeton NJ, US
Patrick Ahl - Princeton NJ, US
Ravi Erukulla - Plainsboro NJ, US
Andrew Janoff - Princeton Junction NJ, US
Assignee:
Transave, Inc. - Monmouth Junction NJ
International Classification:
A61K 9/127
US Classification:
424450000
Abstract:
A liposome including a fusogenic liposome, a linking moiety and a targeting moiety. The fusogenic liposome is a lipid bilayer encapsulating contents. The linking moiety is electrostatically bound to the lipid bilayer, and the targeting moiety is covalently bound to the linking moiety. The liposome may also include a stabilizing moiety interposed between the linking and targeting moieties, and covalently bound to both. Alternatively, the stabilizing and targeting moieties may be covalently bound to separate linking moieties, the linking moieties being electrostatically bound to the lipid bilayer.

Liposomal Peptide-Lipid Conjugates And Delivery Using Same

View page
US Patent:
61437166, Nov 7, 2000
Filed:
Oct 7, 1998
Appl. No.:
9/168010
Inventors:
Paul R. Meers - Princeton Junction NJ
Charles Pak - Plainsboro NJ
Shaukat Ali - Monmouth Junction NJ
Andrew Janoff - Yardley PA
J. Craig Franklin - East Windsor NJ
Ravi K. Erukulla - Plainsboro NJ
Donna Cabral-Lilly - Lawrenceville NJ
Assignee:
The Liposome Company, Inc. - Princeton NJ
International Classification:
A61K 3800
A61K 9127
C07K 500
C07K 700
US Classification:
514 2
Abstract:
Peptide-lipid conjugates are incorporated into liposomes so as to selectively destabilize the liposomes in the vicinity of target peptidase-secreting cells, and hence, to deliver the liposomes to the vicinity of the target cells, or directly into the cells. The liposomes can thus be used to treat mammals for diseases, disorders or conditions, e. g. , tumors, microbial infection and inflammations, characterized by the occurrence of peptidase-secreting cells.

Peptide-Lipid Conjugates

View page
US Patent:
60873256, Jul 11, 2000
Filed:
Oct 15, 1997
Appl. No.:
8/950618
Inventors:
Paul R. Meers - Princeton Junction NJ
Charles Pak - Plainsboro NJ
Shaukat Ali - Monmouth Junction NJ
Andrew Janoff - Yardley PA
J. Craig Franklin - East Windsor NJ
Ravi K. Erukulla - Plainsboro NJ
Donna Cabral-Lilly - Lawrenceville NJ
Assignee:
The Liposome Company, Inc. - Princeton NJ
International Classification:
A61K 3800
A61K 9127
C07K 500
C07K 700
US Classification:
514 2
Abstract:
Peptide-lipid conjugates are incorporated into liposomes so as to selectively destabilize the liposomes in the vicinity of target peptidase-secreting cells, and hence, to deliver the liposomes to the vicinity of the target cells, or directly into the cells. The liposomes can thus be used to treat mammals for diseases, disorders or conditions, e. g. , tumors, microbial infection and inflammations, characterized by the occurrence of peptidase-secreting cells.

Modified Ether Glyceroglycolipids

View page
US Patent:
61537365, Nov 28, 2000
Filed:
Sep 26, 1996
Appl. No.:
8/722881
Inventors:
Robert Bittman - Roslyn Heights NY
Ravi K. Erukulla - Plainsboro NJ
Andrew C. Peters - Yardley PA
Eric G. Mayhew - Monmouth Junction NJ
Assignee:
The Liposome Company, Inc. - Princeton NJ
International Classification:
C07H 1506
C07H 506
A61K 3170
US Classification:
536 41
Abstract:
This invention provides lipids having: 1) a glycerol backbone; 2) a hydrocarbon chain, preferably saturated and containing 16 or 18 carbon atoms, attached to C-1 of the backbone by an ether linkage; 3) a methyl group attached to C-2 of the backbone, preferably by an ether linkage; and, 4) a sugar attached to C-3 of the glycerol backbone in either the alpha or beta anomeric configuration, the sugar being altered by modification of, or substitution for, one or more of its hydroxyl groups. Also provided herein are ether-lipid-containing compositions, as well as methods of administering such compositions to animals, for example, those afflicted with cancers, as well as various other diseases and disorders.
Control profile
Ravi Kumar Erukulla from Dayton, NJ, age ~62 Get Report